EVCARCO (OTC.BB:EVCA) is pleased to present to the shareholders of EVCARCO the latest update from its Italian manufacturer TAZZARI.

Over 6 months have passed since ZERO was launched. While a discerning public admires its technological features, ecological concept, its design and the performance of this all-electric vehicle built using cutting-edge techniques, the TAZZARI team is busy planning and defining the vehicle's coming innovations.

Scott O'Neal, COO of EVCARCO, stated, "As EVCARCO moves forward to find forward thinking, Future Driven, dealers in the U.S. & South America we are excited to be working with TAZZARI as they develop new products, improve advanced technology & performance. We feel that working with an Italian manufacturer with executive styling & sustainable technology will make our future not only greener, but the envy of the road."

EVCARCO Inc. is the Future Driven automotive retail group dedicated to deploying a coast-to-coast network of environmentally friendly franchised dealerships and vehicles. EVCARCO is bringing to market the most advanced clean technologies available in plug-in electric, alternative fuel, and pre-owned hybrid vehicles. EVCARCO has developed a dealer network allowing growth into most US States by 2012.

***********************************

Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) recently announced that it has increased the size of its previously announced underwritten public offering of Common Stock from 4,500,000 shares to 5,500,000 shares and agreed to an indicative price of $28.00 per share for the offering.

Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions.

***********************************

RegeneRx Biopharmaceuticals, Inc. (AMEX: RGN) recently announced that the abstract entitled Treatment of Acute Stroke With Thymosin ß4 has been honored with a score in the top 10 percent of all abstracts presented at the American Heart Association’s specialty conferences during the year, and therefore has been selected for re-presentation as a poster at the AHA’s Scientific Sessions on November 15.

RegeneRx is focused on the development of a novel therapeutic peptide, Thymosin beta 4, or Tß4, for tissue and organ protection, repair and regeneration.

***********************************

Regions Financial Corporation (NYSE: RF) is scheduled to release its third quarter 2010 earnings on Tuesday, October, 26, 2010. Executives from the company will review Regions’ third quarter results via teleconference and live audio webcast beginning at 11 a.m. ET.

Regions Financial Corporation, with $135 billion in assets, is a member of the S&P 100 Index and one of the nation’s largest full-service providers of consumer and commercial banking, trust, securities brokerage, mortgage and insurance products and services.

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received fifteen thousand dollars in cash and thirty-five thousand EVCARCO, Inc. (EVCA.OB) restricted shares for 30 days (which has expired) of advertising services.